Phase II-III double-blind study of oral vinflunine plus best supportive care versus placebo plus best supportive care in patients with malignant pleural mesothelioma previously treated with systemic chemotherapy.

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 11 Jul 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vinflunine (Primary)
Indications Malignant-mesothelioma
Focus Therapeutic Use

Most Recent Events

04 Jul 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
04 Jul 2012 Planned end date 12 Nov 2012 added as reported by European Clinical Trials Database.
04 Jul 2012 Planned number of patients changed from 309 to 396, actual initiation date (12 Nov 2008) added and additional location (France) added as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight